MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 2 filers reported holding MYOVANT SCIENCES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,904 | -96.5% | 659 | -97.7% | 0.00% | -100.0% |
| Q3 2022 | $509,000 | +107.8% | 28,403 | +44.3% | 0.00% | 0.0% |
| Q2 2022 | $245,000 | -8.9% | 19,681 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $269,000 | -12.9% | 20,194 | +1.8% | 0.00% | 0.0% |
| Q4 2021 | $309,000 | -28.6% | 19,834 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $433,000 | -5.7% | 19,334 | -4.1% | 0.00% | 0.0% |
| Q2 2021 | $459,000 | +440.0% | 20,166 | +385.9% | 0.00% | – |
| Q1 2021 | $85,000 | +347.4% | 4,150 | +492.9% | 0.00% | – |
| Q4 2020 | $19,000 | +171.4% | 700 | +37.3% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 510 | +104.0% | 0.00% | – |
| Q2 2020 | $5,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |